Product How it works Pricing Blog FAQ About Contact
Zealand Pharma

Zealand Pharma (CPH: ZEAL) revenue

Zealand Pharma reported revenue of DKK 9,215m for fiscal 2025, 14,598.9% more than in fiscal 2024 (DKK 62.7m). Since fiscal 2019 its revenue has grown by 22,194.2%, an average growth of 146.2% a year.

Fiscal 2025 is the highest of the 7 fiscal years on record for Zealand Pharma. The biggest drop was in fiscal 2024, −81.7%.

Revenue, in millions of Danish kroner41.32019353.32020108.52021104.02022342.8202362.720249,2152025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025DKK 9,215m+14,598.9%DKK 6,959m75.5%
2024DKK 62.7m−81.7%−DKK 1,272m−2,029.3%
2023DKK 342.8m+229.6%−DKK 572.2m−166.9%
2022DKK 104.0m−4.2%−DKK 837.2m−805.1%
2021DKK 108.5m−69.3%−DKK 784.3m−722.6%
2020DKK 353.3m+754.8%−DKK 792.4m−224.3%
2019DKK 41.3m—−DKK 587.9m−1,422.5%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Danish kroner, except per-share amounts.

Zealand Pharma revenue compared with its sector

By revenue for its latest fiscal year, Zealand Pharma ranks 22nd of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Zealand Pharma, 14,598.9%.

RankCompanyRevenueRevenue growth
20thSpire Healthcare Group£1,580m4.5%
21stOrion€1,890m22.5%
22ndZealand PharmaDKK 9,215m14,598.9%
23rdDiaSorin€1,195m0.8%
24thAlmirall€1,108m12.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.

Questions about the revenue of Zealand Pharma

How much revenue did Zealand Pharma make in fiscal 2025?
Zealand Pharma reported revenue of DKK 9,215m for fiscal 2025, compared with DKK 62.7m in fiscal 2024.
How much has the revenue of Zealand Pharma grown?
Between fiscal 2019 and fiscal 2025 it went from DKK 41.3m to DKK 9,215m: 22,194.2% more, an average growth of 146.2% a year.
What was the best year for revenue at Zealand Pharma?
Of its last 7 fiscal years, fiscal 2025, with DKK 9,215m.
Where does Zealand Pharma rank in its sector by revenue?
It ranks 22nd of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Zealand Pharma come from?
From the report Zealand Pharma files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.

Where each figure comes from

From the annual report Zealand Pharma files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2020. More on Zealand Pharma: the Zealand Pharma page · annual accounts · net income.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.